Intellectual Property Law of Plants

ISBN : 9780198700913

Mark D. Janis; Herbert H. Jervis; Richard C. Peet
592 ページ
169 x 246 mm

Plant intellectual property law is a complex proposition which stands apart from other intellectual property endeavours, and this book seeks to elucidate on the key issues involved. This work encompasses aspects of plant innovation and related law in the US and overseas providing a global perspective. Full treatment is given to the legal and technological framework; intellectual property regimes of importance in plant breeding; formal grants of rights under plant variety protection schemes; plant and utility patent regimes and trade mark regimes. Antitrust restrictions on intellectual property licensing and international regulations on plant genetic resources are also covered in detail. All this ensures this text guarantees a comprehensive collection of all useful materials. Written by an expert team of both academics and practitioners, this book is the first to provide unique practical analysis on the creation and implementation of specialised, plant-specific intellectual property regimes.


1. Overview: The Intellectual Property Complex for Plants
2. Innovation in Plant Breeding
3. An Overview of UPOV Systems
4. US Plant Variety Protection
5. Plant Breeders' Rights Outside the US
6. US Plant Patent Protection
7. US Utility Patent Protection
8. Utility Patent Protection for Plants Outside the United States
9. Transactional Law and Plants
10. Variety Denominations, Trade Marks and Unfair Competition Protection
11. Trade Secret Protection
12. Regulations on Plant Genetic Resources


Mark D. Janis is the Robert A. Lucas Chair in Law and Director of the Center for Intellectual Property Research at the Indiana University Maurer School of Law (Bloomington); Herbert H. Jervis is the former Vice President and Chief Intellectual Property Counsel of Pioneer Hi-Bred International, a Dupont Company; Richard C. Peet is a partner with the law firm of Foley & Lardner LLP. He is a former Chair of the firm's Chemical & Pharmaceutical Practice Group and International Business Team. He is an adjunct professor at George Mason University